These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18681777)

  • 41. [Etanercept therapy in rheumatoid arthritis: efficacy and safety].
    Ilić T; Milić B; Ćelić D; Vučković B; Mitić I
    Srp Arh Celok Lek; 2013; 141(7-8):495-502. PubMed ID: 24073556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
    Jobanputra P; Barton P; Bryan S; Burls A
    Health Technol Assess; 2002; 6(21):1-110. PubMed ID: 12387732
    [No Abstract]   [Full Text] [Related]  

  • 43. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
    González-Gay MA; Agudo M
    Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
    [No Abstract]   [Full Text] [Related]  

  • 44. Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis.
    Maxwell JR; Potter C; Hyrich KL; ; Barton A; Worthington J; Isaacs JD; Morgan AW; Wilson AG
    Hum Mol Genet; 2008 Nov; 17(22):3532-8. PubMed ID: 18713756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
    Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis.
    Duffy TN; Genta M; Moll S; Martin PY; Gabay C
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S106. PubMed ID: 16859610
    [No Abstract]   [Full Text] [Related]  

  • 47. [Monitoring of clinical course in TNF inhibitor treatment for rheumatoid arthritis--efficacy evaluation, adverse effect detection, and prediction of clinical response].
    Yamamura M
    Nihon Rinsho; 2007 Jul; 65(7):1269-75. PubMed ID: 17642242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rheumatoid arthritis in pregnancy: successful outcome with anti-TNF agent (Etanercept).
    Sinha A; Patient C
    J Obstet Gynaecol; 2006 Oct; 26(7):689-91. PubMed ID: 17071443
    [No Abstract]   [Full Text] [Related]  

  • 49. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.
    Koike R; Takeuchi T; Eguchi K; Miyasaka N;
    Mod Rheumatol; 2007; 17(6):451-8. PubMed ID: 18084695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Etanercept in rheumatoid arthritis patients with a poor therapeutic response to infliximab].
    Sanmartí R; Gómez-Puerta JA; Rodríguez-Cros JR; Albaladejo C; Muñoz-Gómez J; Cañete JD
    Med Clin (Barc); 2004 Mar; 122(9):321-4. PubMed ID: 15033049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Stable remission of early active rheumatoid arthritis treated with etanercept (Enbrel)].
    Kaliterna DM
    Reumatizam; 2008; 55(2):60-1. PubMed ID: 19024277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etanercept: a review of its use in the management of rheumatoid arthritis.
    Dhillon S; Lyseng-Williamson KA; Scott LJ
    Drugs; 2007; 67(8):1211-41. PubMed ID: 17521223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Etanercept (Enbrel)--our experiences].
    Morović-Vergles J; Martinović-Kaliterna D
    Reumatizam; 2007; 54(2):69-70. PubMed ID: 18351144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
    Nuijten MJ; Engelfriet P; Duijn K; Bruijn G; Wierz D; Koopmanschap M
    Pharmacoeconomics; 2001; 19(10):1051-64. PubMed ID: 11735673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful childbearing in two women with rheumatoid arthritis and a history of miscarriage after etanercept treatment.
    Natsumi I; Matsukawa Y; Miyagawa K; Kodaira H; Tanaka T; Horikoshi A; Takeuchi J; Takei M; Maejima M; Akimoto J
    Rheumatol Int; 2013 Sep; 33(9):2433-5. PubMed ID: 22527141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis.
    Kageyama Y; Kobayashi H; Kato N; Shimazu M
    Mod Rheumatol; 2009; 19(4):372-8. PubMed ID: 19458908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapeutic agents for rheumatoid arthritis: infliximab (a chimeric human IgG 1 monoclonal antibody to TNF-alpha) and etanercept (a soluble form of human TNF type II receptor linked to an IgG 1-Fc moietry)].
    Akiyama Y; Mimura T
    Masui; 2006 Jul; 55(7):864-72. PubMed ID: 16856547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Etanercept: a pharmacoeconomic review of its use in rheumatoid arthritis.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2004; 22(16):1071-95. PubMed ID: 15524495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical progress. On the trail of new arthritis treatments.
    Harv Health Lett; 1997 Nov; 23(1):7. PubMed ID: 15344247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.